LIS for Cancer Genetics Testing
Cancer Genetics
Cancer is considered a genetic disease because it is caused by changes (mutations) to our genes that control the way our cells grow and divide. The changes that cause cancer can be inherited from our family through our parents. Inherited genetic mutations play a vital role in about 5-10% of all cancers. Mutations in specific genes are associated with more than 50 hereditary cancer syndromes as per latest research. These are disorders that predispose individuals to developing certain malignancies.
Genetic testing can tell whether a person with a family history of one of such syndromes has one of these mutations which may make him vulnerable to cancer.
- Labgen excels in all areas of PGx/NGS laboratory LIS such as accessioning, billing integration, and workflow automation.
- As pharmacogenomics (PGx) and Next-Generation Sequencing (NGS) are seeing increased utility and application in the clinical environment, Labgen LIS has developed cutting edge tools to manage these types of testing.
- PGx and NGS focused laboratories must be equipped to solve the data and workflow management, reporting, compliance, and reimbursement policy issues.
Labgen modules
Clinical Lab Module
Automate workflows and operations when performing tests, creating and updating reports and reporting results to physicians.
Microbiology Module
Ensure instruments are calibrated and processes are smooth while keeping full integrity of your data.
Pathology / Cytology Module
Take care of image handling, process tracking, reporting and pathology requests effectively.
Pain Management and Toxicology Module
Streamline workflows surrounding pain management and toxicology testing.
Pharmacogenomics Module
Customize your system to manage all your wet lab activities for all pharmacogenomics testing.
Cancer Genetics Module
Support all workflows, reports, requests and results for your cancer genetics testing.
